Creating a Common Data Model for Comparative Effectiveness with the Observational Medical Outcomes Partnership

被引:65
作者
FitzHenry, F. [1 ,2 ]
Resnic, F. S. [3 ]
Robbins, S. L. [3 ]
Denton, J. [1 ,4 ]
Nookala, L. [1 ,4 ]
Meeker, D. [5 ]
Ohno-Machado, L. [6 ]
Matheny, M. E. [1 ,2 ,4 ,7 ]
机构
[1] Vet Affairs Med Ctr, Tennessee Valley Healthcare Syst, Nashville, TN 37212 USA
[2] Vanderbilt Univ, Dept Biomed Informat, Nashville, TN 37235 USA
[3] Brigham & Womens Hosp, Div Cardiol, Boston, MA 02115 USA
[4] Vanderbilt Univ, Div Gen Internal Med & Publ Hlth, Nashville, TN 37235 USA
[5] RAND Corp, Dept Hlth, Santa Monica, CA USA
[6] Univ Calif San Diego, Div Biomed Informat, San Diego, CA 92103 USA
[7] Vanderbilt Univ, Dept Biostat, Nashville, TN 37235 USA
基金
美国医疗保健研究与质量局;
关键词
Common data model; big data; comparative effectiveness; HEALTH-CARE; BIG DATA; DATABASES; SAFETY; RISK;
D O I
10.4338/ACI-2014-12-CR-0121
中图分类号
R-058 [];
学科分类号
摘要
Background: Adoption of a common data model across health systems is a key infrastructure requirement to allow large scale distributed comparative effectiveness analyses. There are a growing number of common data models (CDM), such as Mini-Sentinel, and the Observational Medical Outcomes Partnership (OMOP) CDMs. Objective: In this case study, we describe the challenges and opportunities of a study specific use of the OMOP CDM by two health systems and describe three comparative effectiveness use cases developed from the CDM. Methods: The project transformed two health system databases (using crosswalks provided) into the OMOP CDM. Cohorts were developed from the transformed CDMs for three comparative effectiveness use case examples. Administrative/billing, demographic, order history, medication, and laboratory were included in the CDM transformation and cohort development rules. Results: Record counts per person month are presented for the eligible cohorts, highlighting differences between the civilian and federal datasets, e. g. the federal data set had more outpatient visits per person month (6.44 vs. 2.05 per person month). The count of medications per person month reflected the fact that one system's medications were extracted from orders while the other system had pharmacy fills and medication administration records. The federal system also had a higher prevalence of the conditions in all three use cases. Both systems required manual coding of some types of data to convert to the CDM. Conclusion: The data transformation to the CDM was time consuming and resources required were substantial, beyond requirements for collecting native source data. The need to manually code subsets of data limited the conversion. However, once the native data was converted to the CDM, both systems were then able to use the same queries to identify cohorts. Thus, the CDM minimized the effort to develop cohorts and analyze the results across the sites.
引用
收藏
页码:536 / 547
页数:12
相关论文
共 47 条
[1]   Estimating the cost of new drug development: Is it really $802 million? [J].
Adams, CP ;
Brantner, VV .
HEALTH AFFAIRS, 2006, 25 (02) :420-428
[2]   Are patients at veterans affairs medical centers sicker?: A comparative analysis of health status and medical resource use [J].
Agha, Z ;
Lofgren, RP ;
VanRuiswyk, JV ;
Layde, PM .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (21) :3252-3257
[3]  
[Anonymous], FDA DRUG SAF COMM UP
[4]  
[Anonymous], 2013, GUID GOOD PHARM PRAC
[5]   The Promise of Pharmacoepidemiology in Helping Clinicians Assess Drug Risk [J].
Avorn, Jerry .
CIRCULATION, 2013, 128 (07) :745-748
[6]  
Berger ML, 2014, J COMP EFFECT RES, V3, P167, DOI [10.2217/cer.14.2, 10.2217/CER.14.2]
[7]  
Bero CL, 2010, AM J MANAG CARE, V16, pSP9
[8]   Health plan switching: Choice or circumstance? [J].
Cunningham, PJ ;
Kohn, L .
HEALTH AFFAIRS, 2000, 19 (03) :158-164
[9]   Applying standardized drug terminologies to observational healthcare databases: A case study on opioid exposure [J].
Defalco F.J. ;
Ryan P.B. ;
Soledad Cepeda M. .
Health Services and Outcomes Research Methodology, 2013, 13 (1) :58-67
[10]  
FitzHenry F, 2013, AM PAIN SOC NAT M 20